ExoDiscovery

#ExoDiscovery had the pleasure of attending the 2024 World Conference on Lung Cancer in San Diego to meet with various stakeholders in fighting lung cancer! The team was represented by Kyusang Lee and Minchan Kim. #WCLC2024 was an opportunity for the #ExoDiscovery team to learn about state-of-the-art practices from leading experts and introduce our #LiquiDyne? platform, a precision cancer diagnostics LDT that enables early detection and monitoring of lung and pancreatic cancers with 10,000x higher sensitivity than qPCR. ExoDiscovery is thrilled to continue our discussions with key opinion leaders on expanding our studies and services, and welcomes scholars and business leaders who would like to join our journey of making ultra-sensitive monitoring of lung and pancreatic cancers possible! If you would like to learn more, please message us on LinkedIn or email us at [email protected]! #WCLC2024 #ExoDiscovery #LungCancer #PancreaticCancer #MolecularDiagnostics #LiquidBiopsy #LiquiDyne

ExoDiscovery is thrilled to announce its partnership with UCSD through the Global Entrepreneur Accelerator (GEA) Program this fall! We are excited to continue our mission of combating cancer with EV-CLIP, our ultra-sensitive early diagnostics technology by expanding our clinical trial network and pharmaceutical partnerships for companion diagnostics. ExoDiscovery is a molecular diagnostics company specializing in extracellular vesicle (“EV”) products, with presence in Boston, San Francisco and Republic of Korea. If you are interested in working with ExoDiscovery on making stages I and II cancer detection possible, please reach out! #cancer #diagnostics #mRNA #liquidbiopsy #biotech #venturecapital #startups